IPO Insider



Highlighted IPO


July 25, 2014 - The IPO for El Pollo Loco Holdings, Inc. (Nasdaq: LOCO) opened for trading at $19 after pricing 7,142,857 shares of common stock at a price to the public of $15.00 per share, the top end of the expected $13.00-$15.00 range.

Jefferies, Morgan Stanley and Baird are acting as joint book-running managers in the proposed offering. William Blair and Stifel are acting as co-managers in the proposed offering.

El Pollo Loco is a differentiated and growing restaurant concept that specializes in fire-grilling citrus-marinated chicken in front of its customers.


Recently Priced IPOs

Date Company Ticker Shares IPO Price Current % Underwriters
9/12/2014 Affimed AFMD 8 Mil $7.00 $6.18 -11.71% Jefferies, Leerink Partners, BMO Capital
9/19/2014 Alibaba BABA 320.106 Mil $68.00 $93.89 38.07% Credit Suisse, Detusche Bank, Goldman Sachs, JP Morgan, Morgan Stanley, Citi
8/14/2014 C1 Financial BNK 2.632 Mil $17.00 $17.00 0.00% Keefe Bruyette Woods and Raymond James
9/17/2014 Civitas Solutions CIVI N/A $17.00 $16.49 -3.00% Barclays, BofA Merrill Lynch, UBS
9/18/2014 Foamix Pharmaceuticals FOMX 5.909 Mil $6.00 $6.15 2.50% Barclays, Cowen and Company
8/8/2014 Green Bancorp GNBC 4.688 Mil $15.00 $16.96 13.07% Sandler O\'Neill + Partners, L.P., Jefferies LLC, J.P. Morgan, RBC Capital Markets and Keefe, Bruyette & Woods
8/8/2014 Independence Contract Drilling ICD 10 Mil $11.00 $11.39 3.55% Morgan Stanley, Barclays.
8/13/2014 Otonomy OTIC 6.25 Mil $16.00 $23.46 46.63% J.P. Morgan Securities LLC and BofA Merrill Lynch
9/12/2014 ReWalk Robotics Ltd. RWLK 3 Mil $12.00 $27.78 131.50% Barclays, Jefferies, Canaccord Genuity
9/17/2014 Tokai Pharmaceuticals TKAI 6.48 Mil $15.00 $18.39 22.60% BMO Capital Markets, Stifel, William Blair

Upcoming IPOs

Date Company Ticker Shares Expected Price Underwriters
Week of 9/15/2014 rEVO Bilogics RBIO 3.6 Mil $13-$15 Piper Jaffray, Guggenheim
Week of 9/15/2014 ProQR Therapeutics PRQR 6.25 Mil N/A Leerink Partners, Deutsche Bank Securities
Week of 9/15/2014 Viking Therapeutics VKTX 5 Mil N/A Oppenheimer & Co. and Roth Capital
N/A China Dredging CLFF N/A N/A Chardan Capital
N/A Greenwich Kahala Aviation Ltd. GKH 15 Mil 12 FBR Capital Markets, Wells Fargo Securities, Cowen and Company, Raymond James
N/A Clarus Therapeutics CLRS 5 Mil 11.00-13.00 Piper Jaffray, Wells Fargo Securities
N/A The Aveon Group L.P. AVO 15.7 Mil 14.00-16.00 J.P. Morgan, Jefferies
N/A Primus Therapeutics, Inc. PRTH N/A N/A Maxim Group LLC
N/A Lighting Science LSGC N/A N/A Credit Suisse, J.P. Morgan, Stifel Nicolaus Weisel, Moelis & Co., Piper Jaffray
N/A Chesapeake Oilfield Services, Inc. COS N/A N/A Goldman Sachs, BofA Merrill Lynch

Upcoming IPO

Yodle plans a $75 million IPO under they symbol "YO". Yodle is a leading provider of cloud-based marketing automation solutions for local businesses that makes digital marketing easy, affordable and transparent. Our platform provides our customers with an online, mobile and social presence, as well as automates, manages and optimizes their marketing activities and other consumer interactions.

Triton Research initiated coverage on the upcoming IPO for Yodle, Inc. (NYSE: YO) (NASDAQ: YO) with a 6.78 rating, which is slightly above the firm's average IPO rating of 6.54.